Wednesday, January 14, 2009

Personalised Medicine: An Opportunity for Investment

The pharmaceutical industry is currently facing some key challenges. The increase in drug development costs, a decrease in the number of drugs being approved, and scrutiny from regulatory authorities are forcing companies to look at alternative revenue generators. Patients themselves are also demanding more effective and safer drugs.

Read the complete article here.

No comments: